T-lymphocyte (green) attacking a cancer cell (blue).

The Cancer Immunotherapy Trials Network, CITN, employs the collective
expertise of top academic immunologists
to design and conduct cancer
therapy trials with the most promising immunotherapy agents prioritized
for high potential in treating cancer, in collaboration with National Cancer Institute,
foundation and industry partners.

Our Vision is to facilitate broad availability of immunotherapy agents, with known and proven biologic function, for treating cancer patients.

Network Clinical Sites:

  • Baylor Research Institute & Mt. Sinai School of Medicine
  • Case Western Reserve University
  • Dana Farber Cancer Center
  • Dartmouth-Hitchcock Norris Cotton Cancer Center
  • Duke University Medical Center
  • Emory University
  • Fred Hutchinson Cancer Research Center
  • MD Anderson Cancer Center
  • H. Lee Moffitt Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • New York University Cancer Institute
  • Ohio State University
  • Providence Cancer Center
  • Roswell Park Cancer Center
  • Rush University Cancer Center
  • Stanford University
  • University of California, San Diego
  • University of California, San Francisco
  • University of Chicago
  • University of Miami
  • University of Minnesota
  • University of Pennsylvania
  • University of Pittsburgh
  • University of Toronto Ontario Cancer Institute
  • University of Virginia
  • University of Wisconsin
  • Yale University
Fred Hutchinson Cancer Research Center UW Medicine